K222281: Intracept Intraosseous Nerve Ablation System (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K222281 (Intracept Intraosseous Nerve Ablation System, cleared 2022-10-26 for Relievant Medsystems, Inc.) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K222281
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK222281
Cleared Device Trade / Generic NameIntracept Intraosseous Nerve Ablation System
FDA Applicant on FilingRelievant Medsystems, Inc.
FDA 3-Letter Product ClassificationProduct Code GXI
FDA Substantial Equivalence Decision Date2022-10-26
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Inspect consolidated manufacturer lineage at Relievant Medsystems, Inc., compare peer devices under FDA Product Code GXI, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.